Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (211-220 of 403) with videos related to

Pageof 41
Sort By:
Plos One|March 3, 2010
The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and diseaseElisabeth Kugelberg, Bridget Gollan, Christopher Farrance, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 5, 2015
Antibody concentrations against the infecting serotype in vaccinated and unvaccinated children with invasive pneumococcal disease in the United Kingdom, 2006-2013Nicholas Brousseau, Nick Andrews, Pauline Waight, et al.
Msphere|April 8, 2025
Methods to evaluate the performance of a multicomponent meningococcal serogroup B vaccineRay Borrow, Laura Tomasi Cont, Daniela Toneatto, et al.
Clinical and Vaccine Immunology : CVI|May 14, 2010
Functional T-cell deficiency in adolescents who experience serogroup C meningococcal disease despite receiving the meningococcal serogroup C conjugate vaccineRachel A Foster, Jennifer Carlring, Andrew Lees, et al.
Microbes and Infection|June 17, 2006
Prospective survey on carriage of Neisseria meningitidis and protective immunity to meningococci in schoolchildren in Niamey (Niger): focus on serogroup W135Amina Amadou Hamidou, Saacou Djibo, Ali Elhaj Mahamane, et al.
Plos One|October 8, 2013
The distribution and 'in vivo' phase variation status of haemoglobin receptors in invasive meningococcal serogroup B disease: genotypic and phenotypic analysisJay Lucidarme, Jamie Findlow, Hannah Chan, et al.
Plos One|February 21, 2012
Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activityJames B Wing, Lynne Smart, Ray Borrow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 27, 2020
First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, EnglandShamez N Ladhani, Helen Campbell, Nick Andrews, et al.
HIV Medicine|April 24, 2023
The propositive study: Immunogenicity and safety of a four-component recombinant protein-based vaccine against MenB and a quadrivalent conjugate MenACWY vaccine in people living with HIVCatherine Isitt, Angela Bartolf, Nick Andrews, et al.
Infection and Immunity|September 23, 2003
Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdomRay Borrow, David Goldblatt, Adam Finn, et al.
Pageof 41

Showing results (211-220 of 403) with videos related to

Sort By:
Pageof 41
Plos One|March 3, 2010
The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and diseaseElisabeth Kugelberg, Bridget Gollan, Christopher Farrance, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 5, 2015
Antibody concentrations against the infecting serotype in vaccinated and unvaccinated children with invasive pneumococcal disease in the United Kingdom, 2006-2013Nicholas Brousseau, Nick Andrews, Pauline Waight, et al.
Msphere|April 8, 2025
Methods to evaluate the performance of a multicomponent meningococcal serogroup B vaccineRay Borrow, Laura Tomasi Cont, Daniela Toneatto, et al.
Clinical and Vaccine Immunology : CVI|May 14, 2010
Functional T-cell deficiency in adolescents who experience serogroup C meningococcal disease despite receiving the meningococcal serogroup C conjugate vaccineRachel A Foster, Jennifer Carlring, Andrew Lees, et al.
Microbes and Infection|June 17, 2006
Prospective survey on carriage of Neisseria meningitidis and protective immunity to meningococci in schoolchildren in Niamey (Niger): focus on serogroup W135Amina Amadou Hamidou, Saacou Djibo, Ali Elhaj Mahamane, et al.
Plos One|October 8, 2013
The distribution and 'in vivo' phase variation status of haemoglobin receptors in invasive meningococcal serogroup B disease: genotypic and phenotypic analysisJay Lucidarme, Jamie Findlow, Hannah Chan, et al.
Plos One|February 21, 2012
Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activityJames B Wing, Lynne Smart, Ray Borrow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 27, 2020
First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, EnglandShamez N Ladhani, Helen Campbell, Nick Andrews, et al.
HIV Medicine|April 24, 2023
The propositive study: Immunogenicity and safety of a four-component recombinant protein-based vaccine against MenB and a quadrivalent conjugate MenACWY vaccine in people living with HIVCatherine Isitt, Angela Bartolf, Nick Andrews, et al.
Infection and Immunity|September 23, 2003
Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdomRay Borrow, David Goldblatt, Adam Finn, et al.
Pageof 41